MitraClip System
Sponsors
Abbott Medical Devices
Conditions
Cardiovascular DiseasesDegenerative Mitral Valve DiseaseFunctional Mitral RegurgitationHeart FailureHeart Valve DiseasesMitral InsufficiencyMitral RegurgitationMitral Valve Insufficiency
Unknown Phase
Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial) and COAPT CAS
NCT01626079
Start: 2012-08-31End: 2024-07-31Updated: 2023-11-27
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Active, not recruitingNCT03433274
Start: 2018-06-15End: 2028-06-01Updated: 2026-07-23
Related Papers
17 more papers not shown